Search the record

ideal locations for the provision of GP services alongside other primary care services. The common conditions service, CCS, recently commenced enabling community pharmacists in Ireland for the very first time to provide advice and treat eight common conditions. This private service is accessible to all patients and will

appointment you will get one within a few days. I know of a 50-year-old woman who went to her pharmacist and was told she had shingles. She rang her GP for an emergency appointment and was told she would get one the following week

options for a future eligibility framework to support the move towards universal health coverage. The common conditions service, CCS, developed to enable community pharmacists in Ireland to provide advice and treat eight common conditions, is a private service delivered in person in registered pharmacies. The CCS is accessible

says we will get the review soon. Why does everything this Government does take so long? The common conditions services provided by pharmacists was also mentioned. The Minister of State said that is accessible to everybody. That is clearly not the case. You have

section 38 and section 39 organisations, private hospitals and private health and social care providers, such as GPs, dentists and pharmacists. The Act contains a provision by which the Minister can add to this list via regulation. Patients and their families must have access, as I have said

reasons we have prioritised that for the pharmacy extension, and in the agreement that we have reached with pharmacists, who are now going to try to proactively register some of their patients on the bowel cancer screening programme in an effort to get more people onto that screening

Deputy Peadar Tóibín asked the Minister for Health the breakdown of the data-sharing protocols between GPs and community pharmacists regarding the distribution of abortion medication; if there is a centralised tracking system to monitor if multiple requests for such medication are made by or for the same

Deputy Ken O'Flynn asked the Minister for Health whether her Department has engaged with representative bodies for community pharmacists, respiratory clinicians, or patient advocacy groups in relation to reimbursement continuity during medicine shortages; whether any formal consultation process has been undertaken since 2020; and if she will

carried out any clinical risk assessment of patients with disabilities, cognitive impairment, or home-care dependency who rely on pharmacist-prepared monitored dosage systems to safely self-administer prescribed medicines; if so, the date of such assessment; the persons that conducted it; and if she will publish

Flynn asked the Minister for Health whether any equality or disability impact assessment has been undertaken in respect of the exclusion of pharmacist-prepared monitored dosage systems from State funding under the long-term illness scheme, having regard to obligations to provide reasonable accommodation for persons with disabilities

Flynn asked the Minister for Health whether her Department recognises that, for some people with disabilities and people receiving home-care supports, pharmacist-prepared monitored dosage systems, including blister packs, are clinically required to ensure safe medication administration and compliance; whether any national clinical guidance, policy circular

Minister for Health whether her Department has undertaken, or commissioned, any patient safety or risk assessment regarding the withdrawal or non-funding of pharmacist-prepared blister packs for people with disabilities or cognitive impairment who rely on such supports in a home-care setting; the findings

needs do not experience disruption to medication compliance supports during the current pause in changes to phased dispensing arrangements; and whether clinicians or pharmacists have discretion to continue such supports where clinically indicated. [10672/26

Deputy Ken O'Flynn asked the Minister for Health the mechanism that exist, or are being considered, whereby a clinician, pharmacist, or multidisciplinary care team may formally certify that monitored dosage systems, including blister packs, are clinically necessary for an individual patient; and whether such certification would permit

Deputy Ken O'Flynn asked the Minister for Health the way in which the non-funding of pharmacist-prepared blister packs aligns with national home-care policy objectives that support independent living for people with disabilities and older persons; and whether her Department accepts that medication compliance supports

withdraw or limit such funding; the policy rationale for that decision; and if she will confirm that essential medication compliance supports, including pharmacist-prepared blister packing, will continue to be covered where clinically indicated. [8227/26